Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Keiichiro, Honma"'
Autor:
Kei Kunimasa, Naotoshi Sugimoto, Tomoyuki Yamasaki, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Mitsuko Kitasaka, Daisuke Sakai, Keiichiro Honma, Toru Wakamatsu, Sachiko Yamamoto, Takuji Hayashi, Seiji Mabuchi, Jun Okuno, Takahisa Kawamura, Yugo Kai, Makiko Urabe, Kazuo Nishimura
Publikováno v:
Cancer Medicine, Vol 13, Iss 18, Pp n/a-n/a (2024)
Abstract Introduction Comprehensive genome profiling (CGP) has revolutionized healthcare by offering personalized medicine opportunities. However, its real‐world utility and impact remain incompletely understood. This study examined the extent to w
Externí odkaz:
https://doaj.org/article/53191da167c842a595bde87157a3ece0
Autor:
Kei Kunimasa, Shingo Matsumoto, Keiichiro Honma, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Satoshi Tanada, Akito Miyazaki, Ryu Kanzaki, Tomohiro Maniwa, Jiro Okami, Yuji Matsumoto, Koichi Goto, Kazumi Nishino
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background It is essential to collect a sufficient amount of tumor tissue for successful next-generation sequencing (NGS) analysis. In this study, we investigated the clinical risk factors for avoiding re-biopsy for NGS analysis (re-genome b
Externí odkaz:
https://doaj.org/article/8068f32a5bac4be8b8a6cb9cbd42ca65
Autor:
Kei Kunimasa, Yosuke Hirotsu, Kenji Amemiya, Keiichiro Honma, Harumi Nakamura, Kazumi Nishino, Masao Omata
Publikováno v:
Thoracic Cancer, Vol 14, Iss 22, Pp 2210-2215 (2023)
Abstract In this study, we investigated the association between PD‐L1 expression in tumor cells and underlying genetic mutations, which was analyzed in detail using laser microdissection and next‐generation sequencing analysis. To investigate whe
Externí odkaz:
https://doaj.org/article/394cbfdb28f54f2783e5a8a89886f7da
Autor:
Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Azusa Shingetsu, Sanako Nishimura, Sayoko Tsuzaki, Ayumi Ryu, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12336-12342 (2023)
Abstract Background Cytology is a fast and simple modality for identifying malignancies and tumor histology. In this study, we analyzed the sensitivity of cytology for liver tumor biopsy and evaluated its potential for prompt clinical diagnosis. Meth
Externí odkaz:
https://doaj.org/article/be6749d4dc1b409bbd0789dd004a5585
Autor:
Tasuku Nakabori, Yutaro Abe, Sena Higashi, Kaori Mukai, Risa Yoshioka, Yuki Morimoto, Yuki Koyanagi, Satoshi Tanada, Shigenori Nagata, Keiichiro Honma, Kazuyoshi Ohkawa
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7888-7892 (2023)
Abstract Aim Appropriate sample selection with a tumor fraction ≥20% without necrosis contamination is required for successful cancer genomic profiling (CGP). Rapid on‐site evaluation (ROSE) is performed to assess adequate sampling. Method This r
Externí odkaz:
https://doaj.org/article/aa67fc75a0844baeb78a49ccc7fe71ad
Autor:
Takashi Kanesaka, Takahiro Inoue, Ayaka Tajiri, Hiromu Fukuda, Kotaro Waki, Satoki Shichijo, Akira Maekawa, Sachiko Yamamoto, Yoji Takeuchi, Koji Higashino, Noriya Uedo, Tomoki Michida, Satoshi Tanada, Keiichiro Honma, Ryu Ishihara
Publikováno v:
JGH Open, Vol 7, Iss 1, Pp 68-71 (2023)
Externí odkaz:
https://doaj.org/article/23f17f1bbe75437e86d04c1a3d45b763
Autor:
Kei Kunimasa, Takako Inoue, Yugo Kai, Ryu Kanzaki, Sachi Kawagishi, Ken‐ichi Yoshida, Keiichiro Honma, Motohiro Tamiya, Takahisa Kawamura, Kazumi Nishino
Publikováno v:
Thoracic Cancer, Vol 14, Iss 1, Pp 85-88 (2023)
Abstract Rapid and reliable identification of targetable driver mutations in patients with advanced stage lung cancer is essential. Adequate amount of tumor tissue biopsies (i.e., genomic biopsies) are required to successfully analyze the gene panel.
Externí odkaz:
https://doaj.org/article/972f9ed6b072498085c902e50ee20f7c
Autor:
Kei Kunimasa, Naotoshi Sugimoto, Takahisa Kawamura, Tomoyuki Yamasaki, Keiichiro Honma, Shigenori Nagata, Yoji Kukita, Fumie Fujisawa, Tazuko Inoue, Yuko Yamaguchi, Mitsuko Kitasaka, Toru Wakamatsu, Takuo Yamai, Sachiko Yamamoto, Takuji Hayashi, Takako Inoue, Motohiro Tamiya, Fumio Imamura, Kazuo Nishimura, Kazumi Nishino
Publikováno v:
Thoracic Cancer, Vol 13, Iss 21, Pp 2970-2977 (2022)
Abstract Background The usefulness of comprehensive genomic profiling (CGP) panels for thoracic malignancies after completion of the standard treatment is unclear. Methods The results of CGP panels for malignant thoracic diseases performed at our hos
Externí odkaz:
https://doaj.org/article/5cced9d17ae34c29aad0192b84e309a7
Autor:
Kei Kunimasa, Shingo Matsumoto, Kazumi Nishino, Keiichiro Honma, Noboru Maeda, Hanako Kuhara, Motohiro Tamiya, Takako Inoue, Takahisa Kawamura, Toru Kimura, Tomohiro Maniwa, Jiro Okami, Koichi Goto, Toru Kumagai
Publikováno v:
Cancer Medicine, Vol 11, Iss 14, Pp 2744-2754 (2022)
Abstract Introduction Success of next generation sequencing (NGS) analysis is becoming indispensable in the treatment of advanced lung cancer. However, the advantages and disadvantages of each sampling method in the NGS analysis have not yet been cla
Externí odkaz:
https://doaj.org/article/978e7bbf0f754bd9ad62e1525b8d6435
Autor:
Tatsuya Nishikawa, MD, PhD, Motohiro Tamiya, MD, PhD, Keiko Ohta-Ogo, MD, PhD, Yoshihiko Ikeda, MD, PhD, Kinta Hatakeyama, MD, PhD, Keiichiro Honma, MD, PhD, Taku Yasui, MD, PhD, Wataru Shioyama, MD, PhD, Toru Oka, MD, PhD, Takako Inoue, MD, PhD, Toru Kumagai, MD, PhD, Masashi Fujita, MD, PhD
Publikováno v:
CJC Open, Vol 4, Iss 7, Pp 651-655 (2022)
Immune checkpoint inhibitor (ICI)-related myocarditis has been reported to appear in the early phase after ICI initiation. Herein, we report the case of a 78-year-old man with non-small cell lung cancer. Pembrolizumab was introduced as first-line the
Externí odkaz:
https://doaj.org/article/01237cec898f4be6bbee853f81fc9bbc